Protein Stability Analysis Market Report 2026

The protein stability analysis market size has grown rapidly in recent years. It will grow from $2.62 billion in 2025 to $2.95 billion in 2026 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to expansion of biologics and biosimilar development, availability of advanced analytical instruments, increased focus on formulation optimization, growth in pharmaceutical R&D spending, wider adoption of stability testing protocols.

The protein stability analysis market size is expected to see rapid growth in the next few years. It will grow to $4.7 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to increasing demand for accelerated stability studies, rising integration of ai-driven data analysis, expansion of contract research services, growing complexity of protein therapeutics, increasing regulatory emphasis on product stability. Major trends in the forecast period include increasing adoption of high-throughput stability testing, rising use of advanced spectroscopy techniques, growing integration of automation in protein analysis, expansion of data-driven stability modeling, enhanced focus on biologic drug development.

The increasing demand for biologics and biosimilars is expected to drive the growth of the protein stability analysis market going forward. Biologics are complex, large-molecule drugs derived from living organisms used to treat a range of diseases, while biosimilars are highly similar, lower-cost versions of approved biologics with no significant clinical differences. The rising demand for biologics and biosimilars is driven by patients and healthcare providers seeking advanced, targeted therapies that offer improved treatment outcomes, greater accessibility, and reduced costs for chronic and complex diseases. Protein stability analysis supports biologics and biosimilars by ensuring their safety, efficacy, and shelf life through monitoring structural integrity and preventing degradation. For instance, according to Samsung Bioepis Co. Ltd., a South Korea-based biopharmaceutical company, in 2024, the US Food and Drug Administration (FDA) approved 45 biosimilars, with 38 of these launched in the US, highlighting strong market uptake relative to total approvals. Therefore, the increasing demand for biologics and biosimilars is driving growth in the protein stability analysis market.

Major companies in the protein stability analysis market are focusing on technological innovations, such as the Veloci biopharma analyzer, to provide advanced molecular fingerprinting tools that improve accuracy, speed, and efficiency in protein characterization and quality assessment. The Veloci biopharma analyzer is an advanced instrument that employs A-TEEM technology to deliver rapid, label-free molecular fingerprinting for life science applications, including protein stability analysis and vaccine characterization. For instance, in March 2025, Horiba Advanced Techno Co. Ltd., a Japan-based analytical solutions and measurement equipment company, launched four new analytical instruments, including a biopharma analyzer with A-TEEM technology, a high-throughput Raman plate reader, and an advanced atomic force microscopy system, designed to enhance molecular fingerprinting, real-time reaction monitoring, and multimodal material analysis. These innovations aim to support key applications in biopharmaceutical research, such as cell culture media analysis, vaccine development, and protein characterization.

In February 2023, Yokogawa Electric Corporation, a Japan-based industrial automation and instrumentation company, acquired Fluence Analytics Inc. for an undisclosed amount. Through this acquisition, Yokogawa aimed to strengthen its real-time analytics and process-monitoring capabilities to accelerate digital transformation and enable more autonomous operations for polymer and biopharmaceutical clients. Fluence Analytics Inc. is a US-based technology company specializing in real-time polymerization and bioprocess analytics through its Automatic Continuous Online Monitoring of Polymerizations (ACOMP) system, which continuously measures and analyzes multiple polymer properties.

Major companies operating in the protein stability analysis market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc, General Electric Healthcare Inc, Agilent Technologies Inc, Charles River Laboratories International Inc, PerkinElmer Inc, Shimadzu Corporation, Sartorius AG, Waters Corporation, Bruker Corporation, HORIBA Ltd, Spectris plc, Unchained Labs Inc, NanoTemper Technologies GmbH, Enzo Life Sciences Inc, Jasco Inc, Setaram Instrumentation SAS, Luminex Corporation, Malvern Panalytical Ltd, BioRad Laboratories Inc, Danaher Corporation, Merck KGaA.

North America was the largest region in the protein stability analysis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the protein stability analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the protein stability analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the protein stability analysis market by increasing costs of imported analytical instruments, chromatography systems, spectroscopy equipment, reagents, and laboratory consumables. Pharmaceutical and biotechnology companies in North America and Europe are most affected due to reliance on imported high-precision instruments, while Asia-Pacific faces higher costs for advanced analytical setups. These tariffs are raising laboratory operating expenses and capital investments. However, they are also encouraging regional instrument manufacturing, localized reagent production, and broader adoption of cost-efficient analytical platforms.

The protein stability analysis market research report is one of a series of new reports that provides protein stability analysis market statistics, including protein stability analysis industry global market size, regional shares, competitors with a protein stability analysis market share, detailed protein stability analysis market segments, market trends and opportunities, and any further data you may need to thrive in the protein stability analysis industry. This protein stability analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Protein stability analysis refers to the evaluation of a protein’s stability under various conditions, such as temperature, pH, solvent composition, or over time. This analysis assesses a protein’s ability to maintain its structure (folded conformation) and function without aggregating or degrading.

The primary product types of protein stability analysis include reagents and assay kits, instruments, consumables and accessories, software, and other products. Reagents and assay kits are chemical substances and pre-packaged tools used in laboratories to detect, measure, or analyze biological or chemical reactions in research, diagnostics, or drug development. These products are categorized by technique into chromatography, spectroscopy, surface plasmon resonance imaging (SPRI), differential scanning calorimetry (DSC), differential scanning fluorimetry (DSF), and others, and are used by end users such as pharmaceutical and biotechnology companies, contract research organizations, academic and research institutes, and others.

The protein stability analysis market consists of revenues earned by entities providing services such as thermal stability testing, structural analysis, and protein stability screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The protein stability analysis market also includes sales of thermal shift assays, circular dichroism spectrometers, and differential scanning calorimetry instruments. Values in this market are 'factory gate' values, meaning the value of goods sold by manufacturers or creators of the products, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market also includes related services sold by the creators of the goods, such as installation, software updates, training, and maintenance support.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.